HMN-154 is a novel benzenesulfonamide compound that acts as a transcriptional inhibitor by targeting the NF-YB subunit, thereby disrupting NF-Y heterotrimer binding to DNA. This mechanism supports its investigation in cancer research, with studies exploring its effects on tumor cell proliferation in both in vitro and in vivo models.
Molekulargewicht:
366.43
Reinheit:
98.25% (May vary between batches)
CAS Nummer:
[173528-92-2]
Formel:
C20H18N2O3S
Target-Kategorie:
Others
Anwendungsbeschreibung:
Solubility: DMSO:15 mg/mL (40.94 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten